17 September 2015 - A parliamentary committee probing access to expensive cancer drugs says a complete review of Australia's medicine system ...
15 September 2015 - Two Public Summary Documents for nintedanib esylate from the March 2015 Pharmaceutical Benefits Advisory Committee (PBAC) meeting ...
15 September 2015 - The public submission process on the Items to be included in the PBAC Guidelines Review is now ...
11 September 2015 - Sigma Pharmaceuticals boss Mark Hooper says the business is in a “good position”, flagging earnings growth on ...
6 September 2015 - Matthew Fijolkowski says he wouldn’t be here today if he hadn’t got access to a miracle treatment ...
4 September 2015 - An opioids roundtable meeting was held on 27 May 2015, and an antibiotics roundtable meeting was held ...
3 September 2015 - The 'Listing Steps (Step 4)' have been updated to include an invitation for comments in relation to ...
3 September 2015 - An update to the examples demonstrating application of the criteria for 'No Reduction Items - Low Volume/Low ...
1 September 2015 - From today, patients with melanoma have access to breakthrough medicine Keytruda on the Pharmaceutical Benefits Scheme. ...
1 September 2015 - Australians with severe psoriasis are about to have affordable access to a new medicine for the debilitating ...
1 September 2015 - The September 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The ...
1 September 2015 - Pembrolizumab has been listed on the Pharmaceutical Benefits Scheme (PBS) today via a Managed Entry Scheme (MES). ...
30 August 2015 - All of the outcomes from the July 2015 PBAC meeting have been entered into the MAESTrO ...
28 August 2015 - Health officials have been savaged over the failure to adequately account for the payment of $14 billion ...
27 August 2015 - The PBAC will consider 69 submissions (34 major & 35 minor) at its next scheduled meeting in ...